Invicta Diagnostic Ltd

NSE: INVICTA · Healthcare · 36 announcements

Share price: ₹66.50
Market cap: ₹83.60 Cr
Revenue (annual): ₹32.35 Cr
Net profit (annual): ₹4.91 Cr
P/E (TTM): 17.0×Sector 53.1×
Promoter holding: 66.70%
FII holding: 4.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 5 Merger & Restructuring 4 Annual General Meeting 4 Acquisition 4 Financial Results 3 Board Meeting Outcome 3 Production Started 2 Other Announcement 2 Earnings Call 2 Board Meeting Date 2 Results Update 1 Product Launch 1 Fund Raise 1 Capacity Expansion 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

20 Jul 2026 20:56 IST NSE

Business Update

Invicta Diagnostic Business Update

Invicta Diagnostic Limited informed the exchange of a partner change in its step-down subsidiary, Porteus Pathogenius LLP. Mr. Mayur Shivdas Kasat has been inducted as a partner.

Read the filing ↗